PATENT CLAIM ANALYSIS

Application Number: 16065285
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-03
Patent Classification: ["424", "450000"]

Abstract:
The presently disclosed subject matter is directed to an RGD peptide and penetrating peptide R8 co-modified ergosterol and cisplatin active drug-loading liposome that is prepared by means of the incubation of an ergosterol and cisplatin active drug-loading liposome, RGD cyclic peptide, and penetrating peptide R8 in a water bath. The ergosterol and cisplatin active drug-loading liposome is prepared from an ergosterol liposome and a cisplatin solution serving as the raw materials. The ergosterol liposome is prepared from 8 wt % to 15 wt % ergosterol and 85 wt % to 92 wt % liposomes, and the liposomes consist of lecithin and cholesterol.

Claim (Index 12):
The RGD peptide and penetrating peptide R8 co-modified ergosterol and cisplatin active drug-loading liposome as claimed in  claim 9 , characterized in that the concentration of the ammonium chloride solution in Step (1) is 0.1-1.5 mmol\u00b7L \u22121 .

Metadata:
- Claim Count in Document: 26.0
- Percentile: 94.0
- Lexical Diversity: 2.16
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15300688', '15129317', '14965140', '14966458', '14632422']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7322750125314682
- 35 USC 102 Novelty (BERT): 0.507907213769597
- Combined Prediction Score: 0.7098382326552811
- Mean Citation Score: 215.694452
- Max Citation Score: 222.31934
- Similarity Product: 133.27155283700228

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test